• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 418402 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1417060873 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1417060873 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Stock Investors Bid Up Shares of Masimo, Up 1.4%

Published on Wed, 01/09/2013 - 11:27
By Adrienne Chilton

Up 1.4% to $19.93, Masimo (NASDAQ:MASI), is one of today's notable movers. The Dow Jones Industrial Average is now trading 0.5% higher to 13,399 and the S&P is trading 0.4% higher to 1,462.

Masimo share prices have moved between a 52-week high of $35.15 and a 52-week low of $17.62 and are now trading 13% above that low price at $19.93 per share. In the last five trading sessions, the 50-day moving average (MA) has fallen 0.6% while the 200-day MA has slid 0.2%.

Masimo (NASDAQ:MASI) has potential upside of 30.0% based on a current price of $19.93 and analysts' consensus price target of $25.92. Masimo shares should first meet resistance at the 50-day moving average (MA) of $20.94 and find additional resistance at the 200-day MA of $21.77.

Masimo Corporation designs, develops and licenses medical signal processing and sensor technology for the noninvasive monitoring of physiological parameters. The Company's first products are designed to improve the effectiveness of pulse oximetry by overcoming the inability of current monitors to precisely measure the levels of arterial blood oxygen saturation and low arterial blood flow.

By Adrienne Chilton
achilton@fnno.com

Latest News from FNNO

Watch for Continued Gains in Shares of V...

Shares of Varian Medical Systems (NYSE:VAR) traded at a new 52-week high today of $89.6 ...

UnitedHealth: The Winning Streak Continu...

Shares of UnitedHealth (NYSE:UNH) traded today at $98.74, breaking its 52-week high. A ...

Texas Instruments: 52-Week High Recently...

Shares of Texas Instruments (NYSE:TXN) traded at a new 52-week high today of $53.74. T ...

Recent 52-Week High Exceeded in Shares o...

Taiwan Semiconductor Manufacturing (NYSE:TSM) traded at a new 52-week high today of $23 ...

Shares of Hanover Insurance Rise Above P...

Shares of Hanover Insurance (NYSE:THG) traded at a new 52-week high today of $71.67. T ...

Recent 52-Week High Exceeded in Shares o...

Taubman Centers (NYSE:TCO) traded today at a new 52-week high of $79.47. So far today ...

Shares of Taser International Have Risen...

Taser International (NASDAQ:TASR) traded at a new 52-week high today of $22.35. Approx ...

Shares of Sunstone Hotel Investors Have ...

Sunstone Hotel Investors (NYSE:SHO) traded at a new 52-week high today of $15.93. This ...